Natalia Beglova Phones & Addresses
-
160 Mill St, Holliston, MA 01746 (508) 893-0667
-
32 Hammond St, Waltham, MA 02451
Work
Position:
Professional/Technical
Public records
Vehicle Records
Natalia Beglova
View pageAddress:
160 N Ml St, Holliston, MA 01746
VIN:
KNDJT2A13A7703258
Make:
KIA
Model:
SOUL
Year:
2010
Publications
Us Patents
Compositions And Methods For Treating Antiphospholipid Syndrome
View pageUS Patent:
20130252887, Sep 26, 2013
Filed:
Oct 31, 2011
Appl. No.:
13/881284
Inventors:
Natalia Beglova - Holliston MA, US
International Classification:
C07K 14/705
US Classification:
514 74, 530350
Abstract:
The invention features compositions and methods of using a dimeric inhibitor, e.g., A1-A1, to selectively target β2GPI in β2GPI/antibody complexes. The compositions can be administered to subjects (e.g., a mammal, such as a human) having or likely to develop APS, or one or more symptoms of APS, in order to treat or inhibit the disease or treat or reduce its symptoms. The inhibitors of the invention include two ligand-binding A1 modules, e.g., from ApoER2, connected by a flexible linker.
Compositions And Methods For Treating Antiphospholipid Syndrome
View pageUS Patent:
20150307581, Oct 29, 2015
Filed:
Feb 20, 2015
Appl. No.:
14/627095
Inventors:
- Boston MA, US
Natalia BEGLOVA - Holliston MA, US
Natalia BEGLOVA - Holliston MA, US
International Classification:
C07K 14/705
Abstract:
The invention features compositions and methods of using a dimeric inhibitor, e.g., A1-A1, to selectively target β2GPI in β2GPI/antibody complexes. The compositions can be administered to subjects (e.g., a mammal, such as a human) having or likely to develop APS, or one or more symptoms of APS, in order to treat or inhibit the disease or treat or reduce its symptoms. The inhibitors of the invention include two ligand-binding A1 modules, e.g., from ApoER2, connected by a flexible linker.